Commercial disputes are the hidden cost of doing business.
@resolutiion_ (@fayola_maria) is building the AI infrastructure to catch delivery risk early.
We're proud to back their $10.4M seed alongside @CherryVentures, @Octopus_UK, Auxxo, @openseedvc & Chevron.
Open Code is back next Wednesday (23rd).
New format. Monthly, longer sessions, voluntary show & tell.
Same results. Vibe coding with vibes. A place to build, meet, and share new side projects.
Apply for a spot: https://t.co/Qzlrh0DnYR
AI has buried video production & editing under stacks of new software tools.
@PooldayAI fixes that. Prompts & existing media assets turned into polished, branded content. The work performed on your behalf.
We're proud to lead Poolday's $11M seed.
Space is Europe's next frontier for sovereignty. @Open_Cosmos is building it.
Raising €300M, Open Cosmos (@rafeljorda) is a satellite intelligence layer for connectivity, observation & intelligence.
We invested in 2018 via @localglobevc & now we're doubling down via Latitude.
@mavenrobotics builds general-purpose robots for warehouses & factories.
Already deployed in a F250 company & eyeing 1M autonomous hours by late 2027.
Founded by @hamzaderbas & Khalid Derbas, we've backed Maven since seed, and again in their $100M Series A via Latitude.
We backed @MistralAI's seed round in 2023, when European frontier AI was just a bet.
Today, they stand alone as the full AI stack for European industry, helping solve its hardest problems.
Congratulations to the team on their €3BN Series D, backed by our late stage fund Solar.
Inside Phoenix Court with Saul Klein - Ep. 1.
Saul Klein is co-founder of @phxcrt, which runs @localglobevc, Latitude and Solar and has backed @Wise, @monzo, @MistralAI and @Figma.
Before venture he co-founded LoveFilm and spent time at @Skype in its early years.
In part one, @ry_paddy and @cape cover:
0:00 Founding Video Island and the road to LoveFilm
5:31 The Screen Select merger and joining Skype
12:18 Learning when to let go
16:33 Why Phoenix Court became a limited company
21:06 Shared ownership, the foundation and long-term thinking
29:37 The power law hiding inside public markets
31:14 Applying that power law to venture
39:24 Back surfers, not waves
43:09 Why seed investing is like 20,000 hairdressers
Biological computation is a new substrate for AI: neurons that learn faster, run cheaper than GPUs.
Frontier is set to launch a 500M-neuron cluster, 2500x the next-largest public system.
We backed their $10M pre-seed w/ General Catalyst, Kaya, Long Journey & Amino Collective.
There is much misunderstanding about the UK’s tech potential. Read Saul Klein below to understand that the new jobs and biggest potential come from the application of tech to existing markets by pioneering young companies, as much if not more than from foundational tech
https://t.co/Z7GbNwEBFp
@meetgranola asked us to put them on an Apple Watch.
Only problem: it didn't exist yet.
A product reveal for something that hadn't been built yet?
Luckily that's exactly what we do at Wonder.
Thank you team Granola @JackCully for trusting us on this one!
Our science for detecting diseases is improving exponentially - but detection devices have barely changed.
Gone are fear-inducing needles & and ugly at-home tests. Meet Early, transforming at-home testing with design at its core.
Waitlist open now: https://t.co/g5IEFExnXO
If AI has democratised technical aspects of film production, where do traditional skills & experience fit in?
@_Xaviercollins_, founder of @WonderStudiosX, outlines the future of filmmaking, with traditional storytelling & craft at its core.
Enterprise AI customer operations was built for everyone, which really meant it was built for no one in financial services. @GradientLabsAI set out to fix that.
Today, they closed a $13M Series A extension. Read more below 👇
We led Gradient Labs' seed round in 2024, and our conviction remains as strong today, as Gradient Labs bring their Series A to $26M.
Now working with the likes of Stash, Rho, Monzo, Zego, and Wise, they’ve reported a 900% revenue growth over the last year.
@BioOrbitSpace might look like a space company, but really it's a new infrastructure layer for pharma.
Today, we're excited to announce we're co-leading their £9.8M seed with @BreegaVC.
Read more below.
Many of the world’s most important drugs (inc. cancer treatments), are still IV-only because they’re too viscous to inject.
BioOrbit, founded by @KKingSpace, uses microgravity to enable crystallisation to accelerate the shift from hospital infusions to at-home treatments.